Analysts expect revenue increase Roche

Tomorrow the Swiss Roche will report its past quarters results. Over the current book year the total revenue will be 62,25 billion CHF (consensus estimates). This is slightly more than 2018's revenue of 56,85 billion CHF.

Historical revenues and results Roche plus estimates 2020

financial analysis

The analysts expect for 2020 a net profit of 16,98 billion CHF. The majority of the analysts expects for this year a profit per share of 19,84 CHF. The price-earnings-ratio equals 16,22.

Per share the analysts expect a dividend of 9,24 CHF per share. The dividend yield is then 2,87 percent. The average dividend yield of the pharmaceutical companies equals a relatively high 2,21177961947037 percent.

Latest estimates around 343 CHF

The most recent recommendations for the pharmaceutical company are from Liberum, Bank of America Merrill Lynch and Jefferies & Co..

Based on the current number of outstanding shares Roche's market capitalization is 223,25 billion CHF. The Roche stock was the past 12 months quite volatile. Since last January the stock is even 29 percent higher. This year the stock price moved between 255 and 332 CHF. Since 2008 the stock price is almost 80 percent higher.

Historical stock prices Roche2007-2020

financial analysis roche

Click here for dividend . At 17.31 the stock trades 1,18 percent higher at 321,75 CHF.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.